Log In
Print
BCIQ
Print
Print this Print this
 

cyclosporine (Sandimmune)

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionCyclosporine
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacrocycle
Latest Stage of DevelopmentMarketed
Standard IndicationRenal transplant rejection
Indication DetailsPrevent renal transplant rejection
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today